In our field, understanding the nuances of post-market surveillance is crucial for demonstrating the long-term efficacy of cardiovascular devices. Recently, I came across data highlighting a 20% increase in device-related adverse events when proper monitoring protocols were not followed. It’s essential that we stay updated on these trends to better inform our clients and maintain trust in the devices we represent.
I’ve noticed that proactively reaching out to clients about post-market issues can really strengthen those relationships. They appreciate being kept in the loop — and it helps maintain trust, especially with stats like a 20% increase in adverse events. How often do you check in with your clients on these topics?
This whole post-market surveillance thing drives me nuts at times! I once worked with a client who experienced a spike in complaints just because they lacked a clear follow-up procedure post-launch. It’s simple, but having a structured monitoring plan really can make a huge difference; you never want to be caught off guard. @kristin_lee77, do you think more training on these protocols could help our teams avoid such pitfalls?